Ophthalmic Drugs Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030

Owingto various reasons, such as growing manufacturing demand, need for specializedfacilities, equipment and operational expertise, and high costs of developmentassociated with certain drugs / therapies, a number of ophthalmic drugdevelopers have demonstrated a preference to outsource certain aspects of drugdevelopment and production operations to contract service providers.

TheUSD 1.7 billion financial opportunity (by 2030) within the OphthalmicDrugs Contract Manufacturing Market has been analyzed across the followingsegments:

Typeof product

·       Ophthalmic API

·       Ophthalmic drug FDF

Typeof FDF manufactured

·       Solid

·       Semi-solid

·       Liquid / suspension

Typeof primary packaging

·       Ampoule / vial 

·       Glass / plastic bottle

·       Ointment tube

·       Blister packing

·       Other forms

Scaleof manufacturing

·       Clinical

·       Commercial

Companysize

·       Small

·       Mid-sized

·       Large

·       Very large

Targetdisease indication

·       Age-related macular degeneration

·       Dry eye

·       Glaucoma

·       Other disease segments

Keygeographical regions

·       North America (US, Canada and Mexico)

·       Europe (UK, Germany, France, Spain, Italy andrest of Europe)

·       Asia-Pacific (India, China, Japan, Australiaand rest of Asia-Pacific)

·       Rest of the world

Requestfor Customization: https://www.rootsanalysis.com/reports/294/request-customization.html

TheOphthalmic Drugs Contract Manufacturing Market: Focus on Active PharmaceuticalIngredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels,Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030report features the following companies, which we identified to be key playersin this domain:

·       Akorn

·       Akums

·       Bal Pharma

·       Catalent

·       Cayman Chemical

·       Entod Pharmaceuticals

·       Farmigea

·       Glenmark Pharmaceuticals

·       Indiana Ophthalmics

·       Lomapharm

·       Medichem

·       Pillar5 Pharma

·       Recipharm

·       Salvat

·       Sterling Pharmaceutical Services

·       Sunways India

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company CompetitivenessAnalysis

6. Ophthalmic Drugs ContractManufacturing in North America: Company Profiles

7. Ophthalmic Drugs ContractManufacturing in Europe: Company Profiles

8. Ophthalmic Drugs ContractManufacturing in Asia-Pacific: Company Profiles

9. Clinical Trial Analysis

10. Capacity Analysis

11. Demand Analysis

12. Market Forecast

13. Case Study: Comparison ofSmall Molecule and Large Molecule Ophthalmic Drugs / Therapies

14. SWOT Analysis

15. Survey Analysis

16. Executive Insights

17. Future GrowthOpportunities

18. Appendix 1: List ofOphthalmic Medical Device Contract Manufacturers

19. Appendix 2: TabulatedData

20. Appendix 3: List ofCompanies and Organizations

GetLatest PDF Sample of this Report:

https://www.rootsanalysis.com/reports/294/request-sample.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415